Results 21 to 30 of about 13,942 (180)
The Effectiveness of Amantadine in Improving Consciousness in Patients with Acute Brain Injury
Archives of Anesthesia and Critical Care, 2023 Background: The improved consciousness level reflects the patient’s recovery following acute brain injury. The medications that can regulate neurotransmitter levels, neural synaptic plasticity, and functional connectivity of consciousness networks might
Alireza Rahat Dahmardeh +3 more
doaj +1 more source
Theoretical Investigation of Amantadine Adsorption on Sc-, Ti-, and Zn-Boron Nitride Nanosheets: DFT, NBO, and QTAIM [PDF]
Nanochemistry Research, 2023 In this work, the potentials of Sc-, Ti-, and Zn-doped BN nanosheets for adsorbing and detecting the amantadine drug were studied by using density functional theory (DFT), natural bond orbital (NBO), and quantum theory of atoms in molecules (QTAIM).
Ebrahim Saedi khosroshahi +4 more
doaj +1 more source
A Case Report of Severe Delirium after Amantadine Withdrawal
Case Reports in Neurology, 2017 Amantadine is frequently used in addition to dopaminergic substances like dopamine agonists or L-Dopa in advanced Parkinson disease (PD). However, adverse effects like hallucinations limit its use.
Franz Marxreiter +3 more
doaj +1 more source
Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials
Brazilian Journal of Psychiatry, 2018 Objective: Amantadine blocks N-methyl-D-aspartate (NMDA) receptors and has dopaminergic and noradrenergic action, a neurochemical profile that suggests its potential as an antidepressant drug.
Inara F. Raupp-Barcaro +3 more
doaj +1 more source
Frontiers in Neurology, 2020 Introduction: Amantadine anecdotally improves gait in progressive supranuclear palsy (PSP) but definitive data is lacking. We investigated associations between amantadine usage, gait, cognition, and activities of daily living in 310 subjects with PSP ...
Marian L. Dale +3 more
doaj +1 more source
Pharmaceuticals, 2023 Blood-to-retina transport across the inner blood–retinal barrier (BRB) is a key determinant of retinal drug concentration and pharmacological effect. Recently, we reported on the amantadine-sensitive drug transport system, which is different from well ...
Yusuke Shinozaki +3 more
doaj +1 more source
Amantadine can induce intra-epithelial deposition in the cornea
American Journal of Ophthalmology Case Reports, 2020 Purpose: Amantadine has been reported to cause various corneal complications, such as superficial punctate keratitis, corneal endothelial dysfunction, and corneal edema.
Asayo Yoshinaka +2 more
doaj +1 more source
Preliminary Study of Intravenous Amantadine Treatment for Ataxia Management in Patients with Probable Multiple System Atrophy with Predominant Cerebellar Ataxia [PDF]
Journal of Movement Disorders, 2012 Background and Purpose: Multiple system atrophy with predominant cerebellar ataxia is a disabling neurologic disease. However, effective management has not yet been established.
Jinyoung Youn +3 more
doaj +1 more source
Right ventricular outflow tract tachycardia after an initial dose of amantadine
Türk Kardiyoloji Derneği Arşivi, 2015 Amantadine hydrochloride is an antiviral agent that is also effective in the treatment of Parkinson's disease. In the literature, cardiac arrhythmia is reported in toxic doses of amantadine, but in this paper we report a patient with right ventricular ...
Cüneyt Kocaş +3 more
doaj +1 more source
Archives of Rehabilitation Research and Clinical TranslationObjectives: To describe the dosing strategy, safety, and effectiveness of amantadine in patients admitted to inpatient rehabilitation after stroke. Design: Retrospective, single-center, cohort study. Setting: Ninety-bed, inpatient rehabilitation hospital.
Haley R. Torr, PharmD +9 more
doaj +1 more source